Stockreport

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics, Inc.  (RNAC) 
PDF GAITHERSBURG, Md., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRN [Read more]